Aim: The aim of this study was to investigate the frequency and correlation between auto-antibodies tosurvivin and MUC1 variable number tandem repeats (VNTR) in colorectal cancer (CRC), which can providevaluable information for the design of immunotherapeutic vaccines for this disease. Methods: Enzyme-linkedimmunosorbent assays (ELISA) were used to examine the level of auto-antibodies against survivin and MUC1VNTR in the serum of 135 CRC patients and 95 healthy volunteers. Results: Using mean absorbance + 2 standarddeviations (SD) of the healthy samples as a cut-off value, the positive rates of survivin and MUC1 VNTR autoantibodiesin CRC were 31.1% and 18.5%, respectively. Altogether, the survivin and MUC1 VNTR positivesamples accounted for 36.3% of the CRC patients, and 7.4% were positive for both. Conclusion: A significantpositive correlation was found between levels of specific antibodies against survivin and MUC1 VNTR in theserum of CRC patients (r = 0.3652, P < 0.0001), suggesting that vaccines against both targets would elicit immuneresponses more effectively.
(2012). Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention, 13(11), 5557-5562.
MLA
. "Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer". Asian Pacific Journal of Cancer Prevention, 13, 11, 2012, 5557-5562.
HARVARD
(2012). 'Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer', Asian Pacific Journal of Cancer Prevention, 13(11), pp. 5557-5562.
VANCOUVER
Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention, 2012; 13(11): 5557-5562.